Synapse - William Tap

Search Within

William Douglas Tap

Results (374)

A retrospective single-center study of outcomes to immune checkpoint blockade-based therapy in leiomyosarcoma

Meeting Abstract

Babatunde, O.; Rosenbaum, E.; Kelly, C. M.; Desir-Camille, R.; Keohan, M. L.; Banks, L.; Avutu, V.; Chan, J.; Reed, D.; Gounder, M.; more...
Annals of Oncology (2024)

Fulltext@MSK | Save

Utility of circulating tumor DNA (ctDNA) as a molecular biomarker in the phase II trial of imatinib plus binimetinib in patients with treatment-naïve, advanced gastrointestinal stromal tumor (GIST)

Meeting Abstract

Kelly, C. M.; Bradic, M.; Saunds, S.; Avutu, V.; Chan, J.; D'Angelo, S. P.; Dickson, M.; Gounder, M.; Keohan, M. L.; Movva, S.; more...
Annals of Oncology (2024)

Fulltext@MSK | Save

An open label phase IIa study evaluating the preliminary efficacy of intratumoural tigilanol tiglate (TT) in advanced and/or metastatic soft tissue sarcoma (STS)

Meeting Abstract

Bartlett, E. K.; Li, D.; Shemla, S.; Ariyan, C. E.; Dickinson, S.; Crago, A.; Li, G.; Agaram, N.; D'Angelo, S. P.; Maki, R. G.; more...
Annals of Oncology (2024)

Fulltext@MSK | Save

A phase II study of palbociclib combined with the PD-1 inhibitor retifanlimab in patients with advanced dedifferentiated liposarcoma

Meeting Abstract

Rosenbaum, E.; Qin, L. X.; Dickson, M.; Movva, S.; Kelly, C. M.; Chan, J.; Chi, P.; Banks, L.; Keohan, M. L.; Gounder, M.; more...
Annals of Oncology (2024)

Fulltext@MSK | Save

A phase I trial of AVA6000, a fibroblast activation protein (FAP)-released, tumor microenvironment (TME)-targeted doxorubicin peptide drug conjugate in patients with FAP-positive solid tumors

Meeting Abstract

Twelves, C. J.; Banerji, U.; Tap, W. D.; Cook, N.; Evans, T. R. J.; Plummer, R.; Anthoney, A.; Plummer, C.; Dawson, R.; Loadman, P.; more...
Annals of Oncology (2024)

Fulltext@MSK | Save

Updated efficacy and safety of vimseltinib in patients (pts) with tenosynovial giant cell tumor (TGCT): One-year follow-up from the MOTION phase III trial

Meeting Abstract

Gelderblom, H.; Bhadri, V. A.; Stacchiotti, S.; Bauer, S.; Wagner, A. J.; van de Sande, M.; Bernthal, N. M.; Lopez Pousa, A.; Abdul Razak, A. R.; Italiano, A.; more...
Annals of Oncology (2024)

Fulltext@MSK | Save

Histology-specific clinical trial of lenvatinib and pembrolizumab in patients with sarcoma

Journal Article

Movva, S.; Seier, K.; Avutu, V.; Banks, L. B.; Chan, J.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Kelly, C. M.; Keohan, M. L.; more...
Clinical Cancer Research (2024)

Fulltext@MSK | Save

GDF-15 predicts epithelioid hemangioendothelioma aggressiveness and is downregulated by sirolimus through ATF4/ATF5 suppression

Journal Article

Stacchiotti, S.; Martini, S.; Pasquali, S.; Frezza, A. M.; Beretta, A.; Percio, S.; Lecchi, M.; Tortoreto, M.; Barisella, M.; Collini, P.; more...
Clinical Cancer Research (2024)

Fulltext@MSK | Save

Dedifferentiated chondrosarcoma: Clinicopathological analysis of 112 cases and correlation of % of dedifferentiation and molecular features to overall survival

Meeting Abstract

Yakoub, M.; Zhu, G. G.; Dermawan, J.; Morris, C.; Hameed, M.; Tap, W.
Laboratory Investigation (2024)

Fulltext@MSK | Save

A multicenter, randomized, non-comparative, phase II study of nivolumab ± ipilimumab for patients with metastatic sarcoma (Alliance A091401): Expansion cohorts and correlative analyses

Journal Article

Seligson, N. D.; Chen, J. L.; Goodrich, A. C.; Van Tine, B. A.; Campbell, J. D.; Richards, A. L.; Antonescu, C. R.; Liebner, D. A.; Milhem, M. M.; Streicher, H.; more...
Journal for ImmunoTherapy of Cancer (2024)

Fulltext@MSK | Save